[1]
R. Paz-Manrique, “ external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) versus EBRT and ADT for patients with localized high risk prostate cancer”., PPCR, vol. 6, no. 1, pp. 3–8, May 2020.